Table 4 Mean Migraine-Specific Questionnaire (MSQ) and Medical Outcome Study Short Form 36 (SF-36) scores at baseline for pooled intent-to-treat (ITT) subjects with < 50% and ≥ 50% reductions in monthly migraine frequency, regardless of study medication*
< 50% Responders | ≥ 50% Responders | |||
|---|---|---|---|---|
MSQ Domain | n | Baseline | n | Baseline |
Emotional Function | 455 | 55.5 | 244 | 55.2 |
Role Prevention | 454 | 68.3 | 243 | 67.0 |
Role Restriction | 455 | 50.1 | 244 | 49.4 |
SF-36 Subscale | n | Baseline | n | Baseline |
Physical Functioning | 454 | 83.1 | 243 | 80.3 |
Bodily Pain | 453 | 51.4 | 244 | 51.6 |
Vitality | 454 | 51.7 | 243 | 50.0 |
General Health | 447 | 68.4 | 242 | 68.3 |
Role-Emotional | 453 | 71.0 | 240 | 68.2 |
Role Physical | 452 | 44.6 | 241 | 44.1 |
Mental Health | 454 | 71.3 | 243 | 70.7 |
Social Functioning | 455 | 69.8 | 244 | 68.6 |
Physical Component Score | 439 | 43.2 | 237 | 42.8 |
Mental Component Score | 439 | 47.4 | 237 | 46.9 |